Familial Cancer is a premier journal dedicated to advancing the understanding of hereditary cancer, published by Springer. With an ISSN of 1389-9600 and E-ISSN 1573-7292, this journal serves as an essential platform for researchers and clinicians focused on the genetic predispositions to cancer and the implications for patient care. Since its inception in 2001, Familial Cancer has built a strong reputation, being consistently ranked in the Q2 category across several key research areas including Cancer Research, Genetics, and Oncology. As of 2023, it holds significant Scopus rankings, reflecting its impactful contributions in the fields of Medicine and Genetics, with a focus on clinical applications. The journal does not currently offer Open Access, emphasizing the commitment to rigorous peer review and high-quality publications. It is vital for emerging researchers and seasoned professionals alike, providing insights into the hereditary aspects of cancer and fostering developments that can lead to better prevention and therapeutic strategies.

Annales de Chirurgie Plastique Esthetique is a prestigious academic journal published by Elsevier, focusing on the dynamic field of plastic and aesthetic surgery. With an ISSN of 0294-1260 and an E-ISSN of 1768-319X, this journal has been at the forefront of surgical innovation since its inception in 1983 and continues to be an essential resource for clinicians, researchers, and students involved in surgery. The journal is positioned in the Q3 quartile of the surgery category, reflecting its growing influence within the discipline, as evidenced by its Scopus rankings of #352 out of 551 in medicine and surgery. Annales de Chirurgie Plastique Esthetique aims to disseminate cutting-edge research, clinical insights, and reviews that advance the practice of plastic surgery. It fosters a platform for dialogue among professionals dedicated to improving patient outcomes through evidence-based approaches and innovative techniques. Although currently not an open-access journal, its commitment to quality and relevance positions it as an invaluable reference point within the surgical community.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

Plastic Surgery is a prestigious peer-reviewed journal published by SAGE PUBLICATIONS INC, focusing on advancements and research in the dynamic field of plastic and reconstructive surgery. With an ISSN of 2292-5503 and an E-ISSN of 2292-5511, this journal aims to disseminate high-quality research that fosters innovation and enhances surgical practice. As of 2023, it holds a Q3 ranking in the Surgery category, reflecting its growing influence within the academic community, evidenced by its Scopus rank of 291 out of 551 and a 47th percentile ranking. The journal is committed to open access, ensuring that groundbreaking studies are accessible to a broad audience, facilitating collaboration and knowledge sharing among researchers, practitioners, and students alike. With a history spanning from 2017 to 2024, Plastic Surgery serves as an essential conduit for the latest insights and methodologies in the field, playing a vital role in shaping future surgical practices.

Journal of Plastic Reconstructive and Aesthetic Surgery is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical innovation and aesthetic practice. Established in 2006 and recognizing its pivotal role in surgery, this journal has proudly maintained a Q1 ranking within its category, placing it among the top 25% of journals in the field. With a solid impact factor and ranking of #180 out of 551 in the Surgery category on Scopus, it is an essential resource for researchers, clinicians, and students who seek to explore groundbreaking studies, clinical techniques, and contemporary issues in plastic and reconstructive surgery. The journal emphasizes open access, ensuring that high-quality research is accessible to a global audience. By consolidating an array of peer-reviewed articles, case studies, and reviews, the Journal of Plastic Reconstructive and Aesthetic Surgery not only contributes to the academic discourse but also fosters innovation that enhances patient care and outcomes.

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

Breast Cancer Research and Treatment, published by Springer, stands as a pivotal journal within the domains of Cancer Research and Oncology, exemplified by its impressive Q2 and Q1 quartile rankings, respectively, in the 2023 category rankings. Since its inception in 1981, this journal has provided a vital platform for disseminating cutting-edge research focused on all aspects of breast cancer, ranging from molecular biology to treatment strategies. With an ISSN of 0167-6806 and E-ISSN of 1573-7217, it captures a broad audience of researchers, clinicians, and students dedicated to improving patient outcomes. The journal emphasizes high-quality, peer-reviewed studies that pave the way for advancements in therapy and direct novel insights into oncological practices. By maintaining a strong ranking in Scopus with percentile placements of 74th in Oncology and 61st in Cancer Research, Brest Cancer Research and Treatment continues to foster innovation and collaboration in the fight against breast cancer.

Breast Cancer-Basic and Clinical Research is a premier open access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of breast cancer through a comprehensive approach that integrates basic and clinical research findings. Since its inception in 2008, this journal has aimed to serve as a vital platform for researchers, healthcare professionals, and students in the fields of oncology and cancer research, providing them with timely access to significant new research, clinical trials, and innovative methodologies. With its current rankings placing it in the Q3 quartile for Cancer Research and Oncology, it reflects a steady commitment to quality and relevance, ranking #167/404 in Medicine - Oncology and #133/230 in Biochemistry, Genetics and Molecular Biology - Cancer Research as of 2023. The journal is designed to foster dialogue and collaboration across disciplines, enabling advancements in therapeutic strategies and patient care. Researchers and professionals will find it an invaluable resource as it continues to push the frontiers of knowledge in breast cancer research.

Current Problems in Cancer: Case Reports is a prominent scholarly journal published by Elsevier, focusing on critical case reports within the field of oncology. Since its transition to Open Access in 2020, it has enhanced accessibility for researchers and healthcare professionals seeking to share and discuss unique clinical scenarios and insights that advance cancer treatment and patient care. Operating from the United States, this journal aims to address the important and often intricate challenges faced in oncology, facilitating a platform for knowledge exchange and the exploration of new perspectives in cancer management. Despite its current Q4 category ranking in the 2023 oncology category of Scopus with a rank of #359/404, its goal is to enrich the academic discourse by featuring diverse case reports and promoting evidence-based practices. As the journal evolves from 2021 to 2024, it seeks to impact the field by inviting researchers, professionals, and students to contribute their findings, ultimately fostering a collaborative environment for tackling the complexities of cancer.

Journal of Breast Cancer, published by the Korean Breast Cancer Society, stands as a pivotal platform for disseminating groundbreaking research and advancements in the field of breast cancer. With an ISSN of 1738-6756 and an E-ISSN of 2092-9900, this open-access journal has been a vital resource since 1998, ensuring that important findings are accessible to all. The journal is situated in South Korea, at 163 Sinmunro 1-ga Jongro-gu, Official Building, Suite 2024, Seoul 110-999, South Korea, fostering an international exchange of knowledge within the scientific community. As a leader in oncology and cancer research, it is categorized in the Q3 quartile for both fields as of 2023, with Scopus rankings reflecting its influence and reach. Researchers and clinicians alike benefit from its rigorous peer-review process and diverse array of articles, which cover the latest studies, treatment strategies, and clinical trials. The Journal of Breast Cancer plays an essential role in shaping future research directions and improving patient outcomes in breast cancer care, making it an invaluable resource for all stakeholders in the oncology field.